Silverarc Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Silverarc Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-94,386	Closed	-$650K	–	97
2022 Q2	$650K	Sell	94,386 -80,382	-46%	-$564K	0.2%	60
2022 Q1	$1.63K	Buy	+174,768	New	+$1.86M	0.67%	38
2021 Q3	–	Sell	-9,679	Closed	-$241	–	114
2021 Q2	$241	Buy	+9,679	New	+$260K	0.11%	90

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Silverarc Capital Management's FMTX Position: Q3 2022 in Review

Silverarc Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2022, closing a stake of 94,386 shares — an estimated $650K sold.

Silverarc Capital Management first reported a position in FMTX in Q2 2021 and held it in 3 quarters. The position peaked at $650K in Q2 2022. 139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

Silverarc Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Silverarc Capital Management sold 94,386 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $650K.
Silverarc Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Silverarc Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $650K in Q2 2022.
139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Silverarc Capital Management's 13F filing for Q3 2022, filed 28 Oct 2022.